Details of the Drug

General Information of Drug (ID: DMCYM9Q)

Drug Name

XT-150

Indication

Disease Entry	ICD 11	Status	REF
Knee osteoarthritis	FA01	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease

Knee osteoarthritis

ICD Disease Classification

FA01

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Interleukin-10 (IL10)	DTT	IL10	1.07E-02	0.08	0.56

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04124042) A Double-Blind, Placebo-Controlled Assessment of the Tolerability and Efficacy of XT-150 for the Treatment of Moderate to Severe Pain Due to Osteoarthritis of the Knee. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Xalud Therapeutics